Food and Drug Administration

Anti-Infective Drugs Advisory Committee

Pediatric Subcommittee

October 29-30, 2003

Briefing Information

Table of Contents (HTM) (PDF) (Word)

Cover Memorandum - Overview (HTM) (PDF) (Word)

Clobex Lotion Label (PDF)

Cutivate® Cream Label (PDF)

Diprolene® AF Cream Label (PDF)

Diprosone® Cream, USP Label (PDF)

Diprosone® Lotion, USP Label (PDF)

Diprosone® Ointment, USP Label (PDF)

Elocon® Cream Label (PDF)

Elocon® Lotion Label (PDF)

Elocon® Ointment Label (PDF)

Lotrtisone® Cream and Lotion (PDF)

Olux® Foam Label (PDF)

Temovate® Cream and Ointment Label (PDF)

Temovate E® Emollient Label (PDF)

Westcort® Cream Label (PDF)

Elidel Cream Approval Letter (PDF)

Elidel® Cream Label (PDF)

Protopic Ointment Appplication Letter (PDF)

Protopic® Ointment Label (PDF)

Memorandum Regarding Postmarketing Safety Review--PID D010141, Dr. Joyce Weaver, PharmD, FDA (HTM) (PDF) (Word)

Memorandum Regarding Safety Review--PID D030565, Dr. Claudia Karwoski, PharmD, FDA (HTM) (PDF) (Word)

Zyrtec® Tablets and Syrup (PDF)

Bibliography (HTM) (PDF) (Word)